Paclitaxel
5 NDCs across 2 manufacturers|5 Generic,0 Brand
Paclitaxel is used to treat breast neoplasms, non-small-cell lung carcinoma, ovarian neoplasms and kaposi sarcoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 29, 1992, and the first generic was approved Jan 25, 2002. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $204K on Paclitaxel across 2,204 claims for 677 beneficiaries.
Paclitaxel is available as 5 NDCs from 2 manufacturers (5 generic, 0 brand), with NADAC prices from $1.77 to $2.13 per ML — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
2
competing in market
Price Spread
$1.77 – $2.13
per ML
7d Activity
avg +0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing PACLITAXEL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PACLITAXEL 30 MG/5 ML VIAL | $2.1290 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL | $1.8891 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL | $1.8891 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL | $1.7700 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL | $1.7700 per ML | — |
Frequently Asked Questions
What is Paclitaxel used to treat?
Paclitaxel is used to treat breast neoplasms, non-small-cell lung carcinoma, ovarian neoplasms and kaposi sarcoma, per the National Library of Medicine's MED-RT classification.
When did Paclitaxel become available as a generic?
FDA approved the first generic Paclitaxel (ANDA) on Jan 25, 2002. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Paclitaxel?
In 2024, Medicare Part D spent $204K on Paclitaxel across 2,204 claims for 677 beneficiaries.
How many Paclitaxel products are on the market?
The Paclitaxel drug market contains 5 NDCs from 2 manufacturers — 5 generic and 0 brand products.
What is the price range for Paclitaxel?
NADAC reference prices for Paclitaxel range from $1.7700 to $2.1290 per ML — a 20% difference between cheapest and most expensive.
Which manufacturers make Paclitaxel?
2 manufacturers list Paclitaxel in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (3), Fresenius Kabi USA, LLC (2).